BioFuse Medical Technologies, Inc. a pioneering medical technology company, is proud to announce that Dr. Neil Hyman, Chief of Colorectal Surgery and Professor of Surgery at the University of Chicago, has been appointed to the BioFuse Clinical Advisory board as a Senior Clinical Advisor. Dr. Hyman is a highly respected surgeon and researcher with extensive experience in colorectal surgery and medical device assessment.
Roland Austrup to join BioFuse Medical Technologies, Inc. Board of Directors as nominated by Innventure, LLC
Roland Austrup to join BioFuse Medical Technologies, Inc. Board of Directors as nominated by Innventure, LLC. Innventure, LLC to provide strategic advisory services to BioFuse Medical Technologies, Inc.
BioFuse Medical Technologies President, Scott R. Sanders, provides update on company’s accomplishments in 2022.
BioFuse Medical Technologies, Inc. appoints Dr. Joe Stauffer as Chairman of the Board of Directors.
Unique tissue RF welding technology showcased at the European Society of Coloproctology 17th Scientific Conference, September 2022.
BioFuse Medical Technologies, Inc., an emerging surgical device company with transformative tissue sealing and welding technology, today announced Joseph Stauffer, DO, MBA, FAPCR, joins the company’s Board of Directors.